Abbott Reports First-Quarter 2022 Results

Go back to Abbott Reports First-Quarter 2022 Results

Abbott Labs (ABT) PT Raised to $142 at CFRA

April 20, 2022 10:57 AM EDT

CFRA raised its price target on Abbott Labs (NYSE: ABT) to $142.00 (from $140.00) while maintaining a Buy rating.

... More